Query author contributions in Reactome
Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.
Details on Person Bruton's tyrosine kinase (BTK) is a cytoplasmic protein tyro...
| Class:Id | Summation:2559413 |
|---|---|
| _displayName | Bruton's tyrosine kinase (BTK) is a cytoplasmic protein tyro... |
| _timestamp | 2014-05-12 13:29:39 |
| created | [InstanceEdit:2559410] Shamovsky, V, 2012-11-02 |
| literatureReference | [LiteratureReference:2201312] Bruton's Tyrosine Kinase is involved in innate and adaptive immunity [LiteratureReference:2201278] Bruton's tyrosine kinase is a Toll/interleukin-1 receptor domain-binding protein that participates in nuclear factor kappaB activation by Toll-like receptor 4 [LiteratureReference:5432711] Bruton's tyrosine kinase is not essential for LPS-induced activation of human monocytes [LiteratureReference:5368304] Bruton's tyrosine kinase is required for lipopolysaccharide-induced tumor necrosis factor alpha production [LiteratureReference:2201306] Bruton's tyrosine kinase phosphorylates Toll-like receptor 3 to initiate antiviral response [LiteratureReference:5432710] Toll-like receptor 4-, 7-, and 8-activated myeloid cells from patients with X-linked agammaglobulinemia produce enhanced inflammatory cytokines [LiteratureReference:5432719] BTKbase: the mutation database for X-linked agammaglobulinemia |
| modified | [InstanceEdit:5432704] Shamovsky, V, 2014-05-12 |
| text | Bruton's tyrosine kinase (BTK) is a cytoplasmic protein tyrosine kinase, which plays an essential role in B cell receptor (BCR) signaling (Brunner C et al. 2005). BTK has been also implicated in TLR signaling (Lee KG et al. 2012, Jefferies CA et al. 2003; Doyle SL et al. 2007). Interaction studies revealed that BTK can associate with intracellular TIR-domains of TLRs 4, 6, 8 and 9. Furthermore, BTK was found to interact with other proteins involved in TLR2/4 signaling - MyD88, MAL and IRAK-1 (Jefferies CA et al. 2003) Loss of BTK function causes X-linked agammaglobulinemia (XLA), a rare primary immunode?ciency disease with severe defects in early B-cell development resulting in an almost complete absence of peripheral B cells and severely reduced serum levels of immunoglobulins of all classes (Väliaho J et al. 2006). Affected individuals suffer from recurrent bacterial and enteroviral infections. It remains unclear whether XLA patients have normal or impared TLR signaling functions. LPS-stimulated monocytes from XLA patients were found to produce reduced amounts of TNFalpha (Horwood NJ et al. 2003), These data contradict a study that showed enhanced amounts of TNFalpha and IL6 comparing to control cells, starting at 6 hours and extending for 48 hours (Marron TU et al. 2012). The other group reported similar expression TNFalpha upon TLR4 triggering, compared with healthy control cells (Perez de Diego R et al. 2006). Thus, the effect of BTK deficiency on TLR-mediated inflammation needs to be further clarified. |
| (summation) | [Reaction:2559414] Activated TLR2/4:TIRAP interacts with BTK [Homo sapiens] |
| [Change default viewing format] | |
